Log in to save to my catalogue

Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antib...

Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antib...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b60d35cbf22c4b359a2ebf2422ce84b2

Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies

About this item

Full title

Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies

Publisher

England: EULAR

Journal title

Rheumatic & musculoskeletal diseases open, 2023-02, Vol.9 (1), p.e002827

Language

English

Formats

Publication information

Publisher

England: EULAR

More information

Scope and Contents

Contents

IntroductionEarly diagnosis of systemic sclerosis (SSc) is important to start therapeutic interventions timely. Important risk factors for progression to SSc are the SSc-specific autoantibodies, of whom anti-centromere antibodies (ACA) and anti-topoisomerase I antibodies (ATA) are the most frequent. ATA is associated with a severe disease course. A...

Alternative Titles

Full title

Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b60d35cbf22c4b359a2ebf2422ce84b2

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b60d35cbf22c4b359a2ebf2422ce84b2

Other Identifiers

ISSN

2056-5933

E-ISSN

2056-5933

DOI

10.1136/rmdopen-2022-002827

How to access this item